This amendment changes to reimbursement methods for ultra-high-cost drugs.

This amendment makes changes to update the reimbursement language for Independent Laboratories.

This plan amendment updates rates for Home Care.

This plan amendment updates rates for Children's System of Care (CSOC).

This SPA allows coverage of medically necessary prescribed drugs that are not covered outpatient drugs, including drugs authorized for import by the U.S. Food and Drug Administration (FDA), during drug shortages. Additionally, this SPA authorizes reimbursement of prescribed drugs that are not considered covered outpatient drugs, with the same reimbursement methodologies as covered outpatient drugs.

This SPA allows Wisconsin to enter into Value-Based Supplemental Rebate Agreements with drug manufacturers on a voluntary basis.

This SPA allows coverage of medically necessary prescribed drugs that are not covered outpatient drugs, including drugs authorized for import by the U.S. Food and Drug Administration (FDA), during drug shortages.

This amendment adds Therapeutic Foster Care to Iowa’s Medicaid State Plan as a Rehabilitative Service.

This amendment will align the Medicaid State Plan with federal law for prior authorizations and prompt payment and will bring California into compliance with the Consolidated Appropriations Act of 2022 (Public Law 117-103). 

This SPA authorizes coverage of select prescribed drugs as well as coverage of drugs authorized for importation by the Food and Drug Administration to mitigate the effects of a drug shortage.